On Monday 15 June, we welcomed an American delegation from Kaiser Permanente, Cedars-Sinai and MD Anderson. The visit was organised by Task Force Health Care as part of Health Tech Europe 2026.
These three major players in American healthcare came to see how new research is translated into value for patients. Not in abstract terms, but in practice. The visit focused on opportunities for scaling up healthcare innovations.
We demonstrated what value-based healthcare looks like in practice. Professor of Diabetology Eelco de Koning opened the programme with CureOne for type 1 diabetes. The delegation then visited the clinic, where they explored LUMC@Home’s remote monitoring programme for heart failure, toured the Willem-Alexander Children’s Hospital for cell and gene therapy, and learned more about image-guided surgery in oncology.
Rather than lengthy presentations, the programme centred on short, practical demonstrations. The day concluded with organ-on-a-chip technology at MIMETAS. This technology originated from research within our ecosystem and now shows in practice how an LUMC spin-off can significantly accelerate drug development.
